Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Waning Measles Immunity in Ontario: A Population-Based Cohort Study

EF 2020-21

Résumé
Immunity derived from the measles vaccine has been shown to decrease over time in countries where measles has been eliminated. This phenomenon is called waning immunity. Canada eliminated measles in 1998 and with increasing measles cases reported globally, waning immunity puts Canada at risk for future outbreaks. Although children are recommended to be vaccinated at 12 months of age, vaccination at older age has been associated with higher long-term immunity. This has been shown in Canada through studies resulting from measles outbreaks, albeit with small sample sizes. We aim to use a large population-based cohort study to examine the effect of age at and time since first dose of measles vaccine on measles immunity using antibody test results from Public Health Ontario (PHO) linked to health administrative data from 2010 to 2019. Results from this study may inform changes to the measles vaccine schedule to optimize measles immunity and ensure that future generations maintain measles elimination status.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
439330
Name
Ariyarajah Archchun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Waning Measles Immunity in Ontario: A Population-Based Cohort Study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Antibody Testing; Health Administrative Data; Infectious Disease Epidemiology; Measles; Population-Level Immunity
Abstract
Immunity derived from the measles vaccine has been shown to decrease over time in countries where measles has been eliminated. This phenomenon is called waning immunity. Canada eliminated measles in 1998 and with increasing measles cases reported globally, waning immunity puts Canada at risk for future outbreaks. Although children are recommended to be vaccinated at 12 months of age, vaccination at older age has been associated with higher long-term immunity. This has been shown in Canada through studies resulting from measles outbreaks, albeit with small sample sizes. We aim to use a large population-based cohort study to examine the effect of age at and time since first dose of measles vaccine on measles immunity using antibody test results from Public Health Ontario (PHO) linked to health administrative data from 2010 to 2019. Results from this study may inform changes to the measles vaccine schedule to optimize measles immunity and ensure that future generations maintain measles elimination status.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ariyarajah, Archchun
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~